Effect of dipeptidyl peptidase-4 inhibitor on emphysema model in mice

被引：0
|
作者：
Joo, H. [1 ]
Kim, J. W. [1 ]
机构：
[1] Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Seoul, South Korea
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Animal models; COPD; Experimental approaches;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3748
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Dipeptidyl Peptidase-4 Inhibitor Improves Steatohepatitis by Targeting Trail Receptor-Mediated Apoptosis Under Modulation of Dipeptidyl Peptidase-4 Expression
    Lee, Sejeong
    Lee, Minyoung
    Shin, Eugene
    Kim, Young-Eun
    Kang, Eun Seok
    Cha, Bong-Soo
    DIABETES, 2020, 69
  • [42] Effect of rifampicin on the pharmacokinetics and pharmacodynamics of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in healthy subjects
    Upreti, Vijay V.
    Boulton, David W.
    Li, Li
    Ching, Agatha
    Su, Hong
    LaCreta, Frank P.
    Patel, Chirag G.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (01) : 92 - 102
  • [43] Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
    Chinda, Kroekkiat
    Palee, Siripong
    Surinkaew, Sirirat
    Phornphutkul, Mattabhorn
    Chattipakorn, Siriporn
    Chattipakorn, Nipon
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (02) : 451 - 457
  • [44] Population Pharmacokinetic Analysis of Dutogliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor
    Marier, Jean-Francois
    Mouksassi, Mohamad-Samer
    Gosselin, Nathalie H.
    Li, Jianke
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (04): : 297 - 304
  • [45] Localized bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor treatment
    Oya, Kazumasa
    Fujii, Masanao
    Taguchi, Shijima
    Nishie, Wataru
    Izumi, Kentaro
    Shimizu, Hiroshi
    EUROPEAN JOURNAL OF DERMATOLOGY, 2018, 28 (02) : 250 - 251
  • [46] The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice
    Nakaoku, Yuriko
    Saito, Satoshi
    Yamamoto, Yumi
    Maki, Takakuni
    Takahashi, Ryosuke
    Ihara, Masafumi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [47] Linagliptin: A Novel Methylxanthin Based Approved Dipeptidyl Peptidase-4 Inhibitor
    Agrawal, Ritesh
    Jain, Pratima
    Dikshit, S. N.
    CURRENT DRUG TARGETS, 2012, 13 (07) : 970 - 983
  • [48] Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetes
    Stein, Stephanie A.
    Lamos, Elizabeth M.
    Davis, Stephen N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (04) : 599 - 608
  • [49] The Metabolism and Disposition of the Oral Dipeptidyl Peptidase-4 Inhibitor, Linagliptin, in Humans
    Blech, Stefan
    Ludwig-Schwellinger, Eva
    Graefe-Mody, Eva Ulrike
    Withopf, Barbara
    Wagner, Klaus
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (04) : 667 - 678
  • [50] IMPACT OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR USE ON THE RISK OF RHEMATOID ARTHRITIS
    Kathe, N. J.
    Shah, A. B.
    Said, Q.
    Painter, J. T.
    VALUE IN HEALTH, 2016, 19 (03) : A225 - A225
12345